madman
Super Moderator
Allopregnanolone: Regenerative therapeutic to restore neurological health (2023)
Gerson D. Hernandez, Roberta D. Brinton
ABSTRACT
Chronic stress has been proposed as a driver of altered brain structure and function, including the pathogenesis of neurodegenerative diseases, and a driver of disease progression. A key outcome of stress in the brain is structural remodeling of neural architecture, which may be a sign of successful adaptation, whereas persistence of these changes when the stress ends indicates failed resilience. Neuroendocrine homeostasis and stress response are mainly dependent upon the functioning of the hypothalamic–pituitary–adrenal axis. Neurosteroids will fluctuate depending on whether the stress is acute or chronic. Advancements in neurosteroid research have led to the identification of multiple targets for drug development, but the most promising innovative target may be neurogenesis, given its potential impact on neurodegenerative disorders like Alzheimer’s disease. Allopregnanolone is an endogenous pregnane neurosteroid and a reduced metabolite of progesterone, which acts as a potent allosteric modulator and direct activator of the GABA-chloride channel complex. Perhaps the most intriguing finding related to the potential therapeutic effects of allopregnanolone is its potential to promote neuroregeneration.
1. Introduction
The central role of the brain in the neurobiology of stress and adaptation has been well documented by Bruce McEwen over many years (B. S. McEwen, 2006, 2007, 2016; Bruce S. McEwen et al., 2015; B. S. McEwen and Gianaros, 2010, 2011). Moreover, the relationship between stress, chronic inflammation, and neurodegenerative disease is well established. Chronic stress has been proposed as a driver of altered brain structure and function, including the pathogenesis of neurodegenerative diseases, and a driver of disease progression (Heneka et al., 2015; Herrera et al., 2015; Hiller, Quinn and Schmidt, 2017; Holmes, 2013; Justice, 2018; Madore, Yin, Leibowitz and Butovsky, 2020; Mishra and Brinton, 2018; Swaab, Bao and Lucassen, 2005; Vyas et al., 2016). According to McEwen and colleagues, a key outcome of stress in the brain is structural remodeling of neural architecture, which may be a sign of successful adaptation, whereas persistence of these changes when the stress ends indicates failed resilience. The underlying mechanisms of plasticity and vulnerability of the brain provide the basis for understanding the efficacy of interventions for anxiety and depressive disorders as well as age-related cognitive decline. (Bruce S. McEwen et al., 2015).
2. Neurosteroids and stress
3. Allopregnanolone and stress
4. Neurogenesis and allopregnanolone
5. Conclusions
The neurobiology of stress plays an important role in chronic inflammation and the development of neurodegenerative diseases. Advancements in neurosteroid research have led to the identification of multiple targets for drug development, but the most promising innovative target may be neurogenesis, given its potential impact on neurodegenerative disorders like Alzheimer’s disease. This target has enabled the development of allopregnanolone as a regenerative therapeutic to restore neurological health.
Gerson D. Hernandez, Roberta D. Brinton
ABSTRACT
Chronic stress has been proposed as a driver of altered brain structure and function, including the pathogenesis of neurodegenerative diseases, and a driver of disease progression. A key outcome of stress in the brain is structural remodeling of neural architecture, which may be a sign of successful adaptation, whereas persistence of these changes when the stress ends indicates failed resilience. Neuroendocrine homeostasis and stress response are mainly dependent upon the functioning of the hypothalamic–pituitary–adrenal axis. Neurosteroids will fluctuate depending on whether the stress is acute or chronic. Advancements in neurosteroid research have led to the identification of multiple targets for drug development, but the most promising innovative target may be neurogenesis, given its potential impact on neurodegenerative disorders like Alzheimer’s disease. Allopregnanolone is an endogenous pregnane neurosteroid and a reduced metabolite of progesterone, which acts as a potent allosteric modulator and direct activator of the GABA-chloride channel complex. Perhaps the most intriguing finding related to the potential therapeutic effects of allopregnanolone is its potential to promote neuroregeneration.
1. Introduction
The central role of the brain in the neurobiology of stress and adaptation has been well documented by Bruce McEwen over many years (B. S. McEwen, 2006, 2007, 2016; Bruce S. McEwen et al., 2015; B. S. McEwen and Gianaros, 2010, 2011). Moreover, the relationship between stress, chronic inflammation, and neurodegenerative disease is well established. Chronic stress has been proposed as a driver of altered brain structure and function, including the pathogenesis of neurodegenerative diseases, and a driver of disease progression (Heneka et al., 2015; Herrera et al., 2015; Hiller, Quinn and Schmidt, 2017; Holmes, 2013; Justice, 2018; Madore, Yin, Leibowitz and Butovsky, 2020; Mishra and Brinton, 2018; Swaab, Bao and Lucassen, 2005; Vyas et al., 2016). According to McEwen and colleagues, a key outcome of stress in the brain is structural remodeling of neural architecture, which may be a sign of successful adaptation, whereas persistence of these changes when the stress ends indicates failed resilience. The underlying mechanisms of plasticity and vulnerability of the brain provide the basis for understanding the efficacy of interventions for anxiety and depressive disorders as well as age-related cognitive decline. (Bruce S. McEwen et al., 2015).
2. Neurosteroids and stress
3. Allopregnanolone and stress
4. Neurogenesis and allopregnanolone
5. Conclusions
The neurobiology of stress plays an important role in chronic inflammation and the development of neurodegenerative diseases. Advancements in neurosteroid research have led to the identification of multiple targets for drug development, but the most promising innovative target may be neurogenesis, given its potential impact on neurodegenerative disorders like Alzheimer’s disease. This target has enabled the development of allopregnanolone as a regenerative therapeutic to restore neurological health.